BASICS OF VETERINARY COMPOUNDING Presented By: Stephanie Montoya, MBA, BS, CPhT.

Similar documents
PROFESSIONAL PRACTICE STANDARD

The College of Veterinarians of Ontario. Guidelines. for the Compounding of Veterinary Drugs

American Veterinary Medical Association

Dosing Your Cat with Azithromycin Pediatric Suspension. By Lorraine Shelton

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

GUIDE TO THE PROFESSIONAL PRACTICE STANDARD

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

They're not all the same: Why FDA approval of animal drugs matters

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/12

THE ADVANTAGES OF cgmp Manufactured Veterinary Drugs

Ohio State Board of Pharmacy Compliance in Veterinary Practice

Beef Producers. The Judicious Use of Antimicrobials for

Veterinary Pharmacy An Introduction Jennifer A. Kelleher, PharmD, BCPS, FSVHP Compounding Pharmacist

BOX 1. NAME OF THE VETERINARY MEDICINAL PRODUCT. Hymatil 300 mg/ml solution for injection for cattle and sheep Tilmicosin

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

SUMMARY OF PRODUCT CHARACTERISTICS

Administering wormers (anthelmintics) effectively

Health Products Regulatory Authority

Proceedings of the 56th Annual Convention of the American Association of Equine Practitioners - AAEP -

Livestock Quality Assurance Education for Youth Producers 2017

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

EXCEDE Sterile Suspension

Center for Veterinary

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

COMPOUNDING REGULATORY PERSPECTIVE

Scientific Discussion post-authorisation update for Rheumocam extension X/007

For Alberta broiler producers, the biggest impacts will be:

2/21/2017. Doctor of Veterinary Medicine (DVM) Veterinary Medical Doctorate (VMD) Board Specialties. Technicians

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

PHARMACIST CLINICIAN:

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Why? The dairy industry is now under increased drug residue surveillance. Meat and Milk Drug Residues: Current Dairy Industry Topics

Session 1: An introduction to the new requirements under the Food and Drug Regulations affecting industry and health care practitioners who compound

Veterinary Pharmacy Issues

Veterinary Drugs Stakeholder Forum Meeting 1 - Summary

Summary of Product Characteristics

SUMMARY OF PRODUCT CHARACTERISTICS. Euthasol vet. 400 mg/ml, solution for injection (AT, BE, DK, EE, EL, FI, IE, IS, LT, LU, LV, NO, PL, RO SE, UK)

Withdrawal period: 93 days Milk: Not authorised for use in animals producing milk for human consumption.

SUMMARY OF PRODUCT CHARACTERISTICS. Pentoject, Pentobarbitone Sodium 200 mg/ml Solution for Injection

FLOXYME 50 mg/ml SOLUTION FOR USE IN DRINKING WATER

Delegating to Auxiliaries in Food Animal & Equine Practice

New Zealand Consumer Medicine Information

[Version 8, 10/2012] SUMMARY OF PRODUCT CHARACTERISTICS

B. PACKAGE LEAFLET 1

Summary of Product Characteristics

Snapshot Current Vet Drugs AMR Initiatives

SUMMARY OF THE PRODUCT CHARACTERISTICS

AMOXICILLIN AND CLAVULANIC ACID TABLETS Draft proposal for The International Pharmacopoeia (February 2018)

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.

Changes in Antibiotic Labeling Veterinary Feed Directive. Changes in Antibiotic Regulations. Concerns with Antibiotic Use 2/29/2016

Technical Requirements for Pharmaceuticals. Experience with submissions of dossiers

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Sheep Medicines POM-V

LABELLING AND PACKAGE LEAFLET

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

DEPOSEL Slow Release Selenium Injection for Cattle and Sheep

SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Emdocam 20 mg/ml solution for injection for cattle, pigs and horses

Guidelines for the preparation and use of compounded pharmaceuticals

SUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur...

Metacam 1.5 mg/ml oral suspension for dogs

SUMMARY OF PRODUCT CHARACTERISTICS

Know how. Know now. Assuring Quality. A guide for youth livestock producers

Meloxicam withdrawal time veterinarian bovine

October 10, 2014 MEMORANDUM

Public Assessment Report Scientific discussion

Procedure # IBT IACUC Approval: December 11, 2017

SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

LUPIN LIMITED SAFETY DATA SHEET. Section 1: Identification MADE IN INDIA

- Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian.

Ear drops suspension. A smooth, uniform, white to off-white viscous suspension.

The VCPR and What Makes it Valid

LUPIN LIMITED SAFETY DATA SHEET. Section 1: Identification. Amlodipine and Valsartan Tablets 5/160 mg, 10/160 mg, 5/320 mg and 10/320 mg

American Association of Feline Practitioners American Animal Hospital Association

Shall be kept clean and in good repair. (a) maintained on every animal and be legibly and accurately documented in a timely manner

The Veterinary Feed Directive. Dr. Dave Pyburn National Pork Board

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Cydectin. Fort Dodge PRODUCT DESCRIPTION

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

The world s first and only pour-on anti-inflammatory for cattle FAST PAIN RELIEF

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

THE IMPORTANCE OF QUALITY IN COMPOUNDED VETERINARY MEDICINES

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.

Essential Skills for Assistant Training Revised 7/1/2018

SINGLE ANNUAL IMPLANT

PART IB1 SUMMARY OF PRODUCT CHARACTERISTICS OCTACILLIN

Metacam. The Only NSAID Approved for Cats in the US. John G. Pantalo, VMD Professional Services Veterinarian. Think easy. Think cat. Think METACAM.

UNAPPROVED VETERINARY DRUGS

UPDATE ON THE ANIMAL MEDICINAL DRUG USE CLARIFICATION ACT OF 1994 REGULATIONS FOR WILDLIFE VETERINARIANS

IMPORTANT SAFETY INFORMATION

Beekeeping for the Future Duane Landals B.Sc.Ag. DVM Senior Advisor Alberta Veterinary Medical Association

SUMMARY OF PRODUCT CHARACTERISTICS. Equest Oral Gel, 18,92 mg/g, Oral Gel for Horses and Ponies

SUMMARY OF PRODUCT CHARACTERISTICS

Transcription:

BASICS OF VETERINARY COMPOUNDING Presented By: Stephanie Montoya, MBA, BS, CPhT. Review veterinary pharmacology List compounding Guidelines (USP 795) OBJECTIVES Choose appropriate equipment and supplies required to compound veterinary preparations Describe different formulations Choose appropriate flavors for palatability Perform calculations necessary to compound veterinary preparations UNITED STATES PHARMACOPEIA (USP) Public health organization that sets the standards for identity, strength, quality, and purity of consumable products. Medication Food ingredients Dietary suppliments Not a regulatory agency USP provides: Official drug monographs Uniform formulations Stability studies Documented Beyond Use Dates (BUD) USP 795 DEFINITION The preparation, mixing, assembling, altering, packaging, and labeling of a drug, drug-delivery device, or device in accordance with a licensed practitioner s, medication order, or initiative based on the practitioner/ patient/ pharmacist/ compounder relationship in the course of professional practice. Compounding includes Preparation of drug dosage forms for both human animal patients Preparation of drugs or devices in anticipation of prescription drug orders based on routine, regularly observed prescribing patterns Reconstitution or manipulation of commercial products that may require the addition of one or more ingredients Preparation of drugs or devices for the purposes of or as an incident to, research (clinical or academic), teaching, or chemical analysis Preparation of drugs and devices for prescriber s office use where permitted by federal and state law COMPOUNDING COMPOUNDING Historically, veterinarians have prepared concoctions, mixtures, and remedies for their patients because there were few approved formulations on the market for animals. Now, there are more available drugs for animals, and pharmaceutical science has provided for a better understanding of the factors contributing to poor drug bioavailability, instability, and physical incompatibility. Over the last several years, questions concerning the practice of compounding have been raised, particularly with respect to stability, purity, and strength when the original dosage form of the drug is altered. A prescription written by a veterinarian generally includes the animal species and/ or pet s name and the name of the owner. A written prescription may be presented at the pharmacy by the patient or caregiver, or it may be transmitted from the prescriber by telephone or by other electronic means 1

BEYOND USE DATES USP 795 The date after which a compounded nonsterile preparation should not be used Nonaqueous Formulations: no longer than 6 months or the earliest expiration date of any ingredient used, whichever is shorter, and stored at controlled room temperatures. Water Containing Oral Formulations: no longer than 14 days or the earliest expiration date of any ingredient used, whichever is shorter, and stored at controlled cold temperatures. This includes water being added as an ingredient or water is a component of any ingredient used. Water Containing Topical/Dermal and Mucosal Liquid and Semisolid Formulations: no longer than 30 days or the earliest expiration date of any ingredient used, whichever is shorter, and stored at controlled room temperatures. This includes water being added as an ingredient or water is a component of any ingredient used If a pharmacist feels that a BUD for a particular product is inadequate, they may use professional judgment to assign a different BUD. The pharmacist should be prepared to defend that judgment. If available, use manufactured products FORMULATION GUIDELINES When manufactured products are not available Find recipes specific to species Find general recipes specific to animals in general Research literatures on excipients. Some excipients can be fatal to animals MEDICATIONS FATAL TO ANIMALS While an (NSAID), like aspirin, ibuprofen, and naproxen, is safe and effective in people, the drug may not be safe and effective in dogs because the drug may: Last longer Have a higher absorption rate in the stomach and small intestine; and Reach higher blood levels. These differences may lead to toxic effects in dogs, such as stomach problems as well as liver and kidney damage. Cats are more sensitive than dogs to the side effects of NSAIDs because they aren t able to break down the drugs as well. Acetaminophen is NOT an NSAID but it is fatal to cats. Hepatotoxicity (dogs) and red blood cell oxidative injury in cats OTHER POTENTIALLY FATAL MEDICATIONS/FOOD Benzocaine if given to Cats can cause Red blood cell oxidative injury, hemolytic anemia Chamomile given to cats causes emesis, diarrhea, depression, lethargy, nose bleed (epistaxis) Chocolate given to Dogs and birds can lead to cardiovascular and central nervous system stimulation Ethyl glycols (diethylene glycol, ethylene glycol) given to dogs and cats can lead to central nervous system toxicity, nephrotoxicity Phenazopyridine in cats can cause hepatotoxicity and red blood cell oxidative injury Pseudoephedrine in both dogs and cats can lead to cardiovascular and central nervous system stimulation Tobacco products given to dogs and cats can lead to muscle weakness, twitching, depression, tachycardia, shallow respiration, collapse, coma, and cardiac arrest Xylitol given to dogs and birds will cause profound hypoglycemia and hepatocellular necrosis COMPOUNDING DEFINED BY FDA Compounding is defined by the Federal Food, Drug, and Cosmetic Act as any manipulation to produce a dose form of a drug in any form other than what is approved by the FDA. Because compounding produces a new drug, it is considered drug manufacture and therefore, as with extra-label use, is subject to all regulations for new drugs. Veterinary compounders should be knowledgeable of formulations developed specifically for Animal patients VETERINARY COMPOUNDING Formulating drugs with flavored compounds (e.g., fish, beef) so they are more readily accepted by a dog or a cat Formulating drugs into capsules or tablets that are no longer available as human drugs (e.g., diethylstilbestrol for urinary incontinence, cisapride for cats with megacolon) Formulating drugs into different forms (e.g., gels, pastes, dermal patches, rectal suppositories) to facilitate administration Formulating a raw chemical into a dose form for administration to animals (e.g., potassium bromide reagent used as an anticonvulsant into a syrup or elixir formulation) 2

EXTRA-LABEL Alteration of any of the following from what is described and approved on the drug label is considered extra-label use: Use in a species not listed Use for an indication (disease or condition) not listed Use of a different dosage Use of a different frequency of administration Use of a different route of administration Deviation from labeled withdrawal time (time from last administration of the drug until the animal or the animal's products can be safely taken to market) Guidelines must be followed for use of animal drugs in an extra-label manner. Only a Veterinarian can authorize extra-label use In 1994 Congress passed the Animal Medicinal Drug Use Clarification Act (AMDUCA) which gave veterinarians the authority to use approved animal drugs in an extra-label manner. A careful medical diagnosis is made by the attending veterinarian within the context of a valid veterinarian-client-patient relationship (VCPR). EXTRA LABEL CONTD. Procedures exist to ensure that the identity of the treated animal is carefully maintained. The prescribed or dispensed extra-label drugs bear labeling information that is adequate to ensure the safe and proper use of the product. This would include the following: Name and address of the prescribing veterinarian The active ingredients Animal the drug is to be used on (identification, class, or species) Dosage, frequency, route of administration, and duration of therapy Any cautionary statements specified by the veterinarian Veterinarian's specified withdrawal/discard time for meat, milk, eggs, or food Products derived from the treated animals Because humans can consume animal patients as food care must be taken to prevent drug residues from entering the human food chain Veterinarians are required by law to provide food producing animal caregivers with an accurate time to withhold treated animal tissues from the food supply of humans Drug use in a performance animal is strictly regulated by federal and state governments. If a violation occurs there is severe penalties to anyone involved THE GOAL OF DRUG THERAPY Maintain a drug in the body within the therapeutic range of concentration. The amount of drug entering the body must be balanced by the rate that the drug leaves the body. Pharmacokinetics is the study of how a drug moves into, through, and out of the body. Pharmacodynamics is the study of how the drug produces its effects on the body. Different dosage forms exist for four main reasons: Ease of administration and thus compliance controlled rate of drug delivery ability to minimize meat or milk withholding times constraints in treating mating animals ANIMAL CATEGORIES Food Herd or flock animals Residues of drugs must be prevented Vets are required to provide a Withdrawal Drug Time (WDT) that must be present on Rx label Companion Cats, dogs, birds, ferrets, gerbils Zoo Animals Performance Animal Competition animals Horses, dogs Highly regulated by federal and state governments ANIMAL SPECIES One of the primary differences between human and veterinary pharmacology is the wide range of dosage forms available to the veterinarian that occurs as a direct consequence of significant differences in the way drugs are administered to animals and humans. These differences are due to the anatomy and physiology of the animal vs. a human, but also due to the behavior and our lack of ability to communicate with them There are at least 24,000 species of fish, 9,000 species of birds, 4,000 kinds of mammals, and 40,000 species of vertebrates. The range of veterinary patient varies widely from birds, fish, and small domestic pets to various farm animals, the thoroughbred horse, and the exotic animal species of the jungle or zoological park. Different species metabolize medications differently CAUTION WHEN USING COMMERCIAL PRODUCTS Some dosage forms should not be used to compound with Modified release ( extended release, delayed release, repeat action, targeted release) Should not be used unless the suitability for use in a preparation has been documented When using solutions the ph of the solution and the ph of the compound should be considered Form Base, Salt, or Ester 3

SPECIAL ANIMAL DOSAGE FORMS ESOPHAGEAL SYRINGE specialized drug delivery devices commonly are used to administer the dosage forms. esophageal syringes drench guns oral tubes designed to deliver medication directly into an animal s stomach pole-mounted syringes and projectile delivery systems, which allow injections to be administered from a safe distance mastitis syringes, for inserting a drug formulation directly into the mammary gland; and others Other methods for drug delivery include: Suspensions Transdermal Gels Poloxamer Gel Chewable treats Capsules Suppositories Solution Pastes Sterile Dosage forms Opthalmic Injectible http://vhc.missouri.edu/wp-content/uploads/2015/06/esophagostomy-tube.jpg DRENCH GUN GASTRIC TUBE http://www.agri-pro.com/media/products/60mldrenchgun_de533319d7dd1.gif?dimensions=499x301 https://horsesidevetguide.com/hsvg/onlinedatabase/media/651.jpg POLE MOUNTED SYRINGE EQUIPMENT AND SUPPLIES NEEDED TO COMPOUND VETERINARY PRODUCTS Balances Weigh boats/paper Capsule Machine Capsules Balances Calibration weights Beakers Bottles & Caps Containers Funnels Graduates Hoods Hot Plates Molds Mortar & Pestle Ointment containers/tubes Pipet & Pipettor Scoops & Scrapers Sealers Spatulas Spoons Stirring Equipment Syringe & Accessories Thermometers Tubes Vials http://www.dan-inject.com/images/daninject/artikelfotos/products/jab_stick/jab_cow_zoom.jpg 4

Master Formulation Record Record of what should be done The name, strength and dosage form of the preparation Calculations required to determine and verify quantities of components and doses of active pharmaceutical ingredients. Description of all ingredients and their quantities Compatibility and stability information, including references if appropriate. Equipment required to prepare preparation Detailed mixing instructions Sample labeling information, including, generic name and quantity or concentration of each active ingredient, assigned BUD, storage conditions, and prescription or control number Container used in dispensing Packaging and storage requirements Description of final preparation Quality control measures and expected results DOCUMENTATION NEEDED Compounding Record Record of what was done Should be completed for every compound that is prepared Name, strength and dosage form of the preparation MFR reference for the preparation Names and quantities of all components Source, lot numbers, and expiration dates of components Total quantity compounded Name of person(s) who prepared the preparation, who performed the quality control procedures, and who approved the preparation Date of preparation Assigned control or RX number Assigned BUD Duplicate label and Description of final preparation Results of quality control procedures Documentation of any quality control issues and any adverse reactions or preparation problems reported by patient or caregiver. DOCUMENTATION Documentation is needed throughout the compounding process Auditing, tracing, and tracking of dispensed products Quality assurance Ensuring the compound is prepared the same everytime Assures reproduceability An MSDS sheet should be kept for every ingredient, and also a Certificate of Analysis should be on file. CALCULATIONS To determine a dose for a particular animal, the following elements need to be known: The weight of the animal The recommended dosage of the drug for animals of this species The concentration of the drug DETERMINE WEIGHT Animal s weight Conversion factor New unit Original unit =Equivalent weight in new units Dog's weight 15kg 2.2lb kg= 33 lb dog Animal's weight Dosage Mass of drug 2 kg cat 50 mg drug kg Body weight DETERMINE TOTAL DOSE =100mg drug = Dose for animal In the event of a dosage range, any number within the range can be used. For example, if a drug has a dosage range of 2 to 4 mg/lb, any of the following would be legitimate doses Dose(Mass) Volume Dose(Mass) Tablet Mass of drug DETERMINE QUANTITY OF EACH DOSE =Amount of dose from to be given Mass of drug =Amount of dose from to be given 5-lb animal needs 10 mg of drug, and given that the drug comes in a liquid concentration of 2 mg/ml, 10mg drug 1mL 2mg = 5mL of liquid to be given 5

COMPOUND: ANIMAL TREATS FOR DRUG INGESTION Powdered animal food 13.2G Glycerin Flavor (chicken, beef, bacon) 1 ml 2 ml Gelatin base 6.6G Active drug Rx makes 3 treats using calibrated dog bone mold add 10% to allow for overfill -Source: The Art, Science, and Technology of Pharmaceutical Compounding: 2nd (second) Edition qs COMPOUND WITH 10% ADDED Set up a formula of Want to get a multiplying factor 3 treats x 0.10= 0.3 + 3= 3.3 treats treats = 1.1 Multiplying Factor= 1.1 Have = 3 Multiply all ingredients by the factor of 1.1 Powdered animal food 13.2G x 1.1= Glycerin 2 ml x 1.1= Flavor (chicken, beef, bacon) 1 ml x 1.1 = Gelatin base 6.6G x 1.1 = Active drug qs PROCEDURE TO COMPOUND RX Calculate enough product to allow for 10%extra (drug loss) Accurately weigh or measure each ingredient Cut the gelatin base into small pieces and melt in a beaker using a water bath while melting Mix the powdered animal food with active ingredient Mix the flavor with the glycerin and add to the melted gelatin Incorporate the powdered animal food/active drug mixture with the glycerin in the beaker Fill desired molds and allow to harden Light liquid petrolatum 20g Aquaphor Compound makes 100g Rx needed is 30g HAIR CONDITIONER FOR HORSES AND OTHER ANIMALS 80g Reduce compound to get amount needed Light Liquid Petrolatum = Aquaphor = Source: The Art, Science, and Technology of Pharmaceutical Compounding: 2nd (second) Edition PROCEDURE TO COMPOUND RX Accurately weigh or measure the calculated quantity of each ingredient Using low heat, heat liquid petrolatum in a beaker Add Aquaphor and thoroughly mix with stirring rod Remove from heat and cool with intermittent stirring Package and label Precipated sulfur 10g Mineral oil 10g White Ointment 80g Compound makes 100g Rx needed is 120g for mange 120g = 100g SULFUR OINTMENT Source: The Art, Science, and Technology of Pharmaceutical Compounding: 2nd (second) Edition 6

PROCEDURE TO COMPOUND RX Calculate the quantity of each ingredient Accurately weigh or measure each ingredient Levigate the precipitated sulfur with the mineral oil until a smooth paste is formed Incorporate the white ointment and mix until uniform Package and label REFERENCES Allen, L., The Art, Science, and Technology of Pharmaceutical Compounding: 2nd (second) Edition., Washington, D.C.: American Pharmacists Association. Ansel, 13 th Edition., Pharmaceutical Calculations., https://pharmacyfunblog.files.wordpress.com/2016/11/pharmaceuticalcalculations-ansel-13th-edition.pdf https://www.fda.gov/animalveterinary/safetyhealth/frequentlyaskedquestions/def ault.htm http://vprcloud.com/major-veterinary-drug-interactions-dogs-cats/ Bill, R. L. (062006). Clinical Pharmacology and Therapeutics for the Veterinary Technician, 3rd Edition [VitalSource Bookshelf version]. Retrieved from https://bookshelf.vitalsource.com/books/978-0-323-01113-6 Riviere, J. E., Papich, M. G. (2017-12-13). Veterinary Pharmacology and Therapeutics, 10th Edition [VitalSource Bookshelf version]. Retrieved from https://bookshelf.vitalsource.com/books/9781118855881 7